Showing results (231-240 of 258) with videos related to
Sort By:
Pageof 26
Journal of Virology|March 27, 2009
Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brainLachlan Gray, Michael Roche, Melissa J Churchill, et al.AIDS Research and Human Retroviruses|August 12, 2017
Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 AntagonistsJacqueline K Flynn, Paula Ellenberg, Renee Duncan, et al.Virology|April 23, 2013
The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsetsJacqueline K Flynn, Geza Paukovics, Miranda S Moore, et al.Retrovirology|August 9, 2020
Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infectionMatthew J Gartner, Paul R Gorry, Carolin Tumpach, et al.Ebiomedicine|March 1, 2021
Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latencyJennifer M Zerbato, Georges Khoury, Wei Zhao, et al.AIDS (London, England)|May 18, 2017
Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndromeThomas A Rasmussen, James McMahon, J Judy Chang, et al.Virology|November 17, 2009
Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infectionJessica Wade, Jasminka Sterjovski, Lachlan Gray, et al.Journal of Virology|August 27, 2025
Contemporary seasonal human coronaviruses display differences in cellular tropism compared to laboratory-adapted reference strainsMatthew J Gartner, Monique L Smith, Clyde Dapat, et al.AIDS (London, England)|December 21, 2022
Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIVMatthew J Gartner, Carolin Tumpach, Ashanti Dantanarayana, et al.Plos Pathogens|January 29, 2026
The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoirYoury Kim, Jenny L Anderson, Carolin Tumpach, et al.Pageof 26